CALIFORNIA,PRESCRIPTION,DISCOUNTS,EQUIVALENTS,POLICY,MEDICINE,TOPICS,OPEN,PAYMENTS,LITIGATION,FDA,INTERNATIONAL,ABOUT ABOUT,ADVERTISING,OPPORTUNITIES,UPDATE,PREVIOUS,ARTICLE,OCTOBER 03,CALIFORNIA ASSEMBLY,SENATE,RECENTLY,FOCUSED,PRICE,PRESCRIPTION DRUGS,LEGISLATION,ASSEMBLY MEMBERS,WOOD,JANUARY 31,THE ASSEMBLY,MAY 31,CALIFORNIA SENATE,SEPTEMBER 12,GOVERNOR JERRY BROWN,TWELVE,DAYS,THE DAY,THE BILLS,PRESENTED,DECIDE,WHETHER,SIGN,VETO,LAW,THE GOVERNOR,SEPTEMBER 20,AT 4,MEANING,THE TWELVE,THE BILL,YESTERDAY,OCTOBER 2,PRESCRIPTION DRUG,MANUFACTURERS,OFFERING,REDUCTIONS,INDIVIDUALS,OUT OF POCKET COSTS,HIS OR HER,INSURANCE,COVERAGE,COST,EQUIVALENT,AVAILABLE,UNITED STATES FOOD AND DRUG,ADMINISTRATION,RISK EVALUATION AND MITIGATION,STRATEGY,REMS,MONITOR,MANNER,CONSISTENT,LABELING,TABLET,DRUG,REGIMEN,PREVENTION OF HUMAN,IMMUNODEFICIENCY,VIRUS,HIV,ACQUIRED IMMUNE DEFICIENCY,SYNDROME,AIDS,EFFECTIVE,MULTI,STEP THERAPY,PRIOR AUTHORIZATION,REQUIREMENTS,BRANDED,HEALTH INSURER,HEALTH CARE SERVICE,PLAN,HEALTH,STATE AGENCY,AUTHORS,RECENT,PROLIFERATION,SOUND,SHOW,CLASSIC,BAIT AND SWITCH,ANALYSIS,THE SENATE,NUMBER,COUPON,OFFERS,TENDERING,FEWER,STUDY,BRAND NAME,MANUFACTURER,REDUCE,CONSUMERS,OUT OF POCKET,SPENDING,REQUIREMENT,GENERALLY,DO NOT,THE PRICE,GOVERNMENT PROGRAM,HEALTH CARE,PAYERS,COMMERCIAL,INSURERS,EMPLOYERS,GOVERNMENT OFFICIALS,DRUG COUPONS,MASK,THE ACTUAL,DRUGS,PROMPT,BENEFICIARIES,ENTERING,BILL,PROPENSITY,RAISE,OUT OF POCKET COST,CITIZENS,THOMAS SULLIVAN,WRITING,STAFF,PRICES,STATE POLICY,COMMENTS,YOU CAN,FOLLOW,CONVERSATION,COMMENT,FEED,POST,VERIFY,YOUR,PREVIEW,ERROR,TYPE,SAVED,MODERATED,APPEAR,AUTHOR,THE LETTERS,NUMBERS,MATCH,THE IMAGE,PLEASE,STEP,POSTING,ENTER,BELOW,AUTOMATED,TROUBLE,READING,IMAGE,VIEW,ALTERNATE,URLS,INFORMATION,NAME,EMAIL ADDRESS,DISPLAYED,VALID,INVALID,NEWSLETTER,SEARCH,RSS FEED,BLOGS,SUN MON TUE WED THU FRI SAT,GUIDANCE,BLUEPRINT,OPIOIDS,FINALIZED,STATE OF THE UNION,TRANSPARENCY,REINTRODUCED,OREGON,EVOLVE,PROVIDERS,MEDPAC,CHANGES,MEDICARE PART D,BIOSIMILARS,COMMISSIONERS,MIPS,FEDERAL GRAND JURY,INDICTS,OPIOID,SCHEME,THE MONSTER IN THE CLOSET,NEW WHO,REPORT,LIGHT ON,PROBLEM,SUBSTANDARD,FALSIFIED,MEDICINES,CATEGORIES,ACADEMIC DETAILING,ACADEMIC ORGANIZATIONS,ACCME,ACCOUNTABLE,CARE,ORGANIZATIONS,ACRE,AFFORDABLE CARE ACT,ANTI,KICKBACK,BIOSIMILAR,CLINICAL RESEARCH,CLINICAL TRIAL,GRANT,DISCLOSURE,COLLABORATIONS,COMPLIANCE,CONFLICT OF INTEREST,CONGRESS,CORPORATE,INTEGRITY,SHORTAGES,EDITORIALS,ELECTRONIC HEALTH RECORDS,EVENTS,EXECUTIVE BRANCH,FALSE CLAIMS ACT,GOVERNMENT AGENCIES,GOVERNMENT,REGULATION,GUIDELINES,HEALTHCARE REFORM,HHS OIG,HIPAA,ICD 10,INNOVATION,INSTITUTE OF MEDICINE,LETTERS,SCIENCE,MAINTENANCE OF CERTIFICATION,MASSACHUSETTS,CODE OF CONDUCT,MEDIA,MEDICAL JOURNALS,MEDICAL,LEGAL,SOCIETIES,MEDICARE,MEMORIAL,NATIONAL,PHYSICIAN,PAYMENT,PROGRAM,RESOURCES,PATIENT,PATIENT PROTECTION,PCORI,PDUFA,DEVICE,PHARMACY,SUNSHINE ACT,RULE,TOP 50,THINGS,QUALITY IMPROVEMENT,RESEARCH,SAMPLE,REPORTING,SOCIAL MEDIA,ARCHIVES,